Research Report Covers the Global Cardiovascular Device Market 2023

Cardiovascular Implants Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of Cardiovascular Implants Market by type (coronary stents, peripheral stents, heart valves, implanted cardiac pacemakers, implantable cardioverter defibrillator and cardiac resynchronization therapy device) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the Cardiovascular Implants Market it includes the five years Industry analysis and the 6 years annual forecast from 2017 to 2023. Some of the prominent participants in the Global Cardiovascular Implants Market are Abbott Laboratories, B-Braun, Boston Scientific, Medtronic plc., St. Jude Medical, Inc., C. R. Bard, Inc., Cook Medical, Terumo Corporation, Edwards Lifesciences and AMG International. According to the report the Global Cardiovascular Implants Market is projected to grow at a CAGR of 6.1% in terms of value over the period of 2017-2023.

CVDs includes coronary artery diseases (CAD) such as angina and myocardial infarction (heart attack). Other CVDs are peripheral arterial disease, stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous thrombosis. There various treatment options available in the market to treat these cardiovascular diseases such as drug therapy (ACE inhibitors, antiarrhythmic, aspirin therapy, beta-blocker therapy, clot buster drugs, diuretics, etc.), changing lifestyle habits, and medical surgeries (stents, coronary stents, peripheral stents, heart bypass surgery, pacemakers, implantable cardioverter defibrillators, and heart transplants). These implants are lifesaving medium to improve the patient’s disease condition and are made of various materials, which includes metals, alloys, biomaterials, and polymers.


Driving Factors Attributing To the Growth of This Include Increasing Number of Patients with Cardiovascular Diseases Such As Hypertension, Heart Failures and Coronary Artery Diseases


Some of the key driving factors attributing to the growth of this include increasing number of patients with cardiovascular diseases such as hypertension, heart failures and coronary artery diseases, and shortage of number of heart donors. In addition, changing lifestyle, alcohol consumption, growing obesity and smoking further propelling the market growth, as these factors increase the bold glucose and lipid levels, which results in serious cardiovascular diseases. According to American Heart Association publication, it has been estimated that in the US alone approximately 5.5 million people suffered from heart failure in 2013 and 300,000 die each year because of heart failure. The market for global cardiovascular implants was valued at USD 26.1 billion in 2015 and is expected to reach around USD 39.0 billion by 2023, growing at a CAGR of 5.8% during the forecast period of 2017 to 2023. However, there are certain restraining factors which could hamper the growth of the market, which includes, high-risk nature and high complication rates associated with considerable mortality, due to frequent use of implants in older populations with frequent co-morbidities. Geographically, North America is leading contributor to the market and is expected to retain its position during the forecast period. Nonetheless, the market for Asia-Pacific region is expected to grow at a faster rate owing to increasing prevalence of CVD diseases, growing awareness among the population, improving healthcare infrastructure, rise in healthcare spending, and favorable government policies.

Table of Contents:-

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

3. Global Cardiovascular Implants Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter’s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.5. Competitive Landscape in the Global Cardiovascular Implants Market

4. Global Cardiovascular Implants Market by Type

4.1. Coronary Stents

4.2. Peripheral Stents

4.3. Heart Valves

4.4. Implanted Cardiac Pacemakers

4.5. Implantable Cardioverter Defibrillator

4.6. Cardiac Resynchronization Therapy (CRT) Device

5. Global Cardiovascular Implants Market by Region 2017-2023

5.1. North America

5.1.1. North America Cardiovascular Implants Market by Type

5.1.2. North America Cardiovascular Implants Market by Country

5.2. Europe

5.2.1. Europe Cardiovascular Implants Market by Type

5.2.2. Europe Cardiovascular Implants Market by Country

5.3. Asia-Pacific

5.3.1. Asia-Pacific Cardiovascular Implants Market by Type

5.3.2. Asia-Pacific Cardiovascular Implants Market by Country

5.4. RoW

5.4.1. RoW Cardiovascular Implants Market by Type

5.4.2. RoW Cardiovascular Implants Market by Sub-region

6. Company Covered

6.1. Abbott Laboratories

6.2. B-Braun

6.3. Boston Scientific

6.4. Medtronic Plc.

6.5. St. Jude Medical, Inc.

6.6. C. R. Bard, Inc.

6.7. Cook Medical

6.8. Terumo Corporation

6.9. Edwards Lifesciences

6.10. AMG International

Click the Below Full Report Link: –

Reset Password